All Tests, Women's Health
a woman smiles holding her phone outside after checking her test results

HPV Cervical Cancer Screening Test

A simple exam-free option for cervical cancer screening.

The HPV Cervical Cancer Screening Test is a self‑collected vaginal swab that screens for the 14 high‑risk types of human papillomavirus (HPV) that are associated with cervical cancer. HPV is a very common virus, and certain high‑risk types can cause changes in cervical cells over time. Staying up to date on cervical cancer screening is an important part of preventive health and is recommended by the American Cancer Society for those age 25 through 65 with a cervix.1 This test can be an empowering step in staying informed.

 

With this test, you can collect your own sample privately at a Labcorp patient service center—providing a convenient exam-free alternative to a traditional pap smear for adults at average risk. Knowing your HPV status can help you make informed decisions about your health and any recommended follow‑up with a healthcare professional.

 

Note: This test is intended for adults age 25-65+ at average risk for cervical cancer and may not be appropriate for those at increased risk. Talk to your healthcare provider to discuss if the HPV Cervical Cancer Screening Test is right for you. See below and in the FAQs for guideline recommendations.

$ 179.0
$179
HPV Cervical Cancer Screening Test
$ 179.0
$179

Test Details

blood sample icon
Sample Type: Vaginal Swab
building icon
Collection Method: In person at a Labcorp location
number icon
Age: 18-100
laptop icon
Results: 2-4 days from when your sample arrives at our lab
note icon
HSA/FSA: Accepted
intended user icon
Test must be taken by purchaser

Preparation: Avoid using vaginal ovules, creams or washes, and vaginal contraceptives or condoms during the three days before self‑collecting a vaginal sample.

Avoid sexual intercourse, ultrasound scans, and gynecological examinations during the two days before self‑collecting a vaginal sample.

What's Tested
  • High-Risk Human Papilloma Virus (HPV) Types

    This test screens for high-risk HPV types that may lead to cervical cell changes and increase the risk of cervical cancer over time. It is intended for adults age 25-65+ at average risk for cervical cancer and is not appropriate for those at increased risk. Knowing your status can guide conversations with your healthcare provider about appropriate follow‑up.

FAQ

  • A pap smear looks for abnormal cervical cells, while an HPV test looks for the virus that can cause those changes. Because high-risk HPV drives most cervical cancers, screening guidelines support HPV testing as an effective screening method for average-risk adults age 25-65+.
     

    Self-collected HPV testing offers an FDA approved, exam-free screening option for many people, but pelvic exams may still be needed in some cases.  While this test screens for HPV, it’s also important to note what it cannot do. This test does not diagnose cancer, test for low-risk HPV types and does not replace regular pelvic exams when recommended by a healthcare professional. 

  • Yes. High‑risk HPV often has no symptoms. That’s why regular cervical cancer screening, including HPV testing or pap smears, is so important.1 Low‑risk HPV types (types 6 and 11, not included in this test) may cause genital warts, but these are different from the types linked to cervical cancer.2
     

    Note: Unexplained vaginal symptoms (such as abnormal bleeding, unusual discharge, or pain) require consultation with a healthcare provider for appropriate evaluation.3

  • You are likely considered average risk—and eligible for this self-collected HPV test—if all of the following are true:
     

    • You are 25-65 years old and have a cervix
    • You do not have vaginal or pelvic symptoms
    • You do not have a history of abnormal cervical screening results for which more frequent follow-up was needed or required
    • You have never had cervical cancer or treatment for high-grade cervical changes
    • You are not immunocompromised (including HIV, immunosuppressive medications or conditions)
    • You were not exposed to diethylstilbestrol (DES) before birth4

     

    If you are unsure of your risk level, ask your healthcare provider which test and screening schedule is best for you. People at increased risk often require clinician-collected cervical samples and more frequent screening or monitoring.

  • This test checks for 14 high‑risk types of HPV most linked with cervical cancer using a self‑collected vaginal swab in a Labcorp patient service center.

     

    Your results are reported in two parts:
     

    1. HPV 16 and HPV 18 results

    These two HPV types are reported separately because they carry the highest risk for cervical cancer. Knowing the results for HPV 16 and HPV 18 individually helps a healthcare provider determine the most appropriate care plan.
     

    2. A combined result for 12 other high-risk HPV types which includes:

    HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68.

  • Instructions are provided for you to collect your own vaginal sample in private at a Labcorp patient service center using a simple FDA approved collection swab. Our trusted laboratory analyzes the sample for high‑risk HPV types associated with cervical cancer risk. Your results will indicate whether high‑risk HPV was detected, helping guide the next steps.

  • For self-collected vaginal HPV tests, repeat screening is recommended every 3 years when test results are all negative.1 If you’re unsure when your next screening should be, your healthcare provider can help you decide the right timing based on your health history and test results.

  • As part of this test purchase, you are eligible to discuss your results with a healthcare provider at no additional cost to you when your test results are positive for the presence of high-risk HPV.
     

    Note: The consultation provided with our independent provider network does not include providing treatment or writing prescriptions. Your healthcare consultation will help you understand recommended follow‑up care and management options.
     

    If your test results are positive for the presence of high-risk HPV, you will be contacted by a healthcare provider from our independent provider network to discuss your results one‑on‑one. The virtual consultation ensures that you can discuss your results in a comfortable, private and stigma‑free space. The provider can answer questions and provide personalized guidance to help with the next steps, so you aren’t left wondering what to do.

  • No. This test does not diagnose cancer. A positive screening test for high-risk HPV requires follow-up with a healthcare provider to determine the most appropriate next steps. A healthcare provider will develop a personalized care plan that could involve additional testing, monitoring, colposcopy (biopsy) or treatment.

  • Yes. There is a safe and effective HPV vaccine recommended for both males and females to help prevent HPV-related cancers. The vaccine series can be started as early as age 9 and is routinely recommended through age 26 for those who were not vaccinated earlier. It offers the most protection when given before any exposure to HPV.5
     

    It is still recommended to screen for high-risk HPV even if you are vaccinated.1 The HPV vaccine does not protect against all types of high-risk HPV types that may lead to cancer. 

  • Your testing will be performed in a CLIA-certified clinical laboratory. Labcorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. Our labs perform regular quality assurance testing to ensure our results are accurate.

  • Your results will be provided to you through our secure online portal to view or print. Results are also made available through a secure portal to the independent healthcare provider who placed your test order.  If you are accessing your results through your Labcorp Patient™ account, all users linked to the account will have access to all OnDemand test results. Results may also be provided to a local, state, and/or federal health authority; for example, many states require the testing laboratory and physician to report test results for certain communicable diseases, such as COVID-19, to local or state health departments.  

     

    If you have questions or comments regarding the Labcorp Notice of Privacy Practices, or have a complaint about our use or disclosure of your PHI or our privacy practices, please contact: privacyofficer@labcorp.com, call us at (877) 234-4722 (877-23-HIPAA) and ask for the Labcorp HIPAA Privacy Officer, or send a written request to: HIPAA Privacy Officer, Labcorp, 531 South Spring Street, Burlington, NC 27215. You also may file a complaint with the Secretary of the U.S. Department of Health and Human Services.

  • Visit the Labcorp OnDemand® website to browse and purchase laboratory tests and create your Labcorp Patient™ account to view your results. All Labcorp OnDemand testing requires an order from an authorized healthcare professional. For your convenience, Labcorp OnDemand has contracted with independent professional entities (collectively, Providers) to deliver healthcare provider services. Visit a Labcorp location for sample collection; or, if using an at-home collection kit, collect your sample yourself. We’ll let you know when your results are ready and can be accessed through your Labcorp Patient™ account.

  • To align with clinical best practices, we’ve set an age maximum of 100 for consumer-initiated testing. This limit was set to encourage individuals in more advanced age groups - who may have complex medical needs - to receive personalized guidance about testing from their healthcare providers.